All lobbying filings

The McManus Group

The McManus Group filed a Q3 report for Vialase Inc. on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Vialase Inc. · Ophthalmic Medical Device Company

As filed: THE MCMANUS GROUP for VIALASE INC.

All filings by The McManus Group · Everything Vialase Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Education on ophthalmic medical devices.

Medicare/Medicaid

Patient access and reimbursement of ophthalmic medical devices. Issues related to patient access to glaucoma treatment in 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.